ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
2 2025
Изменен: 30.04.2025Путь: Главная / Публикации
ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
11401 11402 11403 11404 11405 11406 9644 11291 11407 11408 7666 11409 11410 11411 11412 2 2025
Изменен: 30.04.2025Путь: Главная / Басты бет / Жарияланымдар
ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
... viral hepatitis, 12 patients received antiviral treatment between 2021 and 2023. Treatment regimens included pangenotypic DAAs for HCV (Sofosbuvir/Velpatasvir) and nucleos(t)ide analogs for HBV (entecavir or tenofovir). Sustained virological response (SVR12 and SVR24), liver function parameters, fibrosis regression (assessed via FibroScan), and adverse events were recorded. Results: Of the 12 patients, 9 were HCV-positive (genotypes 1, 1b, or 3), 2 had HBV, and 1 had mixed HBV+HCV infection. All HCV ...
Изменен: 30.04.2025Путь: Главная / Home / Publications
Результаты поиска 1 - 3 из 3
Начало | Пред. | 1 | След. | Конец
Отсортировано по релевантности | Сортировать по дате